Novartis plans to sell its listed company in India, according to Narasimhan, Global CEO
Novartis, the Swiss pharmaceutical powerhouse, is contemplating a strategic shakeup in India, hinting at the potential divestment of its listed unit, Novartis India Limited (NIL). However, amidst this potential shift in ownership dynamics, the company remains steadfast in its commitment to expanding its research and development (R&D) footprint in the country through its unlisted unit, […]